262 related articles for article (PubMed ID: 25517101)
1. Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca(2+) dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat.
Avalos-Fuentes A; Albarrán-Bravo S; Loya-Lopéz S; Cortés H; Recillas-Morales S; Magaña JJ; Paz-Bermúdez F; Rangel-Barajas C; Aceves J; Erlij D; Florán B
Neurobiol Dis; 2015 Feb; 74():336-46. PubMed ID: 25517101
[TBL] [Abstract][Full Text] [Related]
2. Presynaptic CaMKIIα modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a Ca²⁺ dependent manner.
Avalos-Fuentes A; Loya-López S; Flores-Pérez A; Recillas-Morales S; Cortés H; Paz-Bermúdez F; Aceves J; Erlij D; Florán B
Neuropharmacology; 2013 Aug; 71():273-81. PubMed ID: 23602989
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D3 receptor modulates D2 receptor effects on cAMP and GABA release at striatopallidal terminals-Modulation by the Ca
Villalobos-Escobedo FS; Jijón-Lorenzo R; Avalos-Fuentes JA; Paz-Bermúdez F; Recillas-Morales S; Rojas IC; Leyva-Gómez G; Cortés H; Florán B
Eur J Neurosci; 2024 Apr; 59(7):1441-1459. PubMed ID: 38151481
[TBL] [Abstract][Full Text] [Related]
4. Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects.
Albarrán-Bravo S; Ávalos-Fuentes JA; Cortés H; Rodriguez-Sánchez M; Leyva-García N; Rangel-Barajas C; Erlij D; Florán B
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480516
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of D
Campos Campos B; Ávalos-Fuentes A; Piña Leyva C; Sánchez-Zavaleta R; Loya-López S; Rangel-Barajas C; Leyva-Gómez G; Cortés H; Erlij D; Florán B
Synapse; 2020 Aug; 74(8):e22152. PubMed ID: 32068305
[TBL] [Abstract][Full Text] [Related]
6. D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat.
Cruz-Trujillo R; Avalos-Fuentes A; Rangel-Barajas C; Paz-Bermúdez F; Sierra A; Escartín-Perez E; Aceves J; Erlij D; Florán B
Neuropharmacology; 2013 Apr; 67():370-8. PubMed ID: 23238327
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 10A controls D1-mediated facilitation of GABA release from striato-nigral projections under normal and dopamine-depleted conditions.
Mango D; Bonito-Oliva A; Ledonne A; Nisticò R; Castelli V; Giorgi M; Sancesario G; Fisone G; Berretta N; Mercuri NB
Neuropharmacology; 2014 Jan; 76 Pt A():127-36. PubMed ID: 23973317
[TBL] [Abstract][Full Text] [Related]
8. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
[TBL] [Abstract][Full Text] [Related]
9. 6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat.
Rangel-Barajas C; Silva I; García-Ramírez M; Sánchez-Lemus E; Floran L; Aceves J; Erlij D; Florán B
Neuropharmacology; 2008 Oct; 55(5):704-11. PubMed ID: 18588904
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
Lanza K; Chemakin K; Lefkowitz S; Saito C; Chambers N; Bishop C
Psychopharmacology (Berl); 2020 Jan; 237(1):155-165. PubMed ID: 31435690
[TBL] [Abstract][Full Text] [Related]
11. Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII.
Liu XY; Mao LM; Zhang GC; Papasian CJ; Fibuch EE; Lan HX; Zhou HF; Xu M; Wang JQ
Neuron; 2009 Feb; 61(3):425-38. PubMed ID: 19217379
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D(1) receptor facilitation of depolarization-induced release of gamma-amino-butyric acid in rat striatum is mediated by the cAMP/PKA pathway and involves P/Q-type calcium channels.
Arias-Montaño JA; Floran B; Floran L; Aceves J; Young JM
Synapse; 2007 May; 61(5):310-9. PubMed ID: 17318879
[TBL] [Abstract][Full Text] [Related]
13. D4 and D1 dopamine receptors modulate [3H] GABA release in the substantia nigra pars reticulata of the rat.
Acosta-García J; Hernández-Chan N; Paz-Bermúdez F; Sierra A; Erlij D; Aceves J; Florán B
Neuropharmacology; 2009 Dec; 57(7-8):725-30. PubMed ID: 19715708
[TBL] [Abstract][Full Text] [Related]
14. Decreased Caffeine-Induced Locomotor Activity via Microinjection of CART Peptide into the Nucleus Accumbens Is Linked to Inhibition of the pCaMKIIa-D3R Interaction.
Fu Q; Zhou X; Dong Y; Huang Y; Yang J; Oh KW; Hu Z
PLoS One; 2016; 11(7):e0159104. PubMed ID: 27404570
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of D2/D3 receptors increases efficacy of ropinirole in chronically 6-OHDA-lesioned Parkinsonian rats.
Matsukawa N; Maki M; Yasuhara T; Hara K; Yu G; Xu L; Kim KM; Morgan JC; Sethi KD; Borlongan CV
Brain Res; 2007 Jul; 1160():113-23. PubMed ID: 17573046
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic Dopamine D2 Receptors Modulate [
Jijón-Lorenzo R; Caballero-Florán IH; Recillas-Morales S; Cortés H; Avalos-Fuentes JA; Paz-Bermúdez FJ; Erlij D; Florán B
Neuroscience; 2018 Feb; 372():74-86. PubMed ID: 29292080
[TBL] [Abstract][Full Text] [Related]
17. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
18. Regulation of dopamine D3 receptors by protein-protein interactions.
Guo ML; Liu XY; Mao LM; Wang JQ
Neurosci Bull; 2010 Apr; 26(2):163-7. PubMed ID: 20332822
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling.
Solís O; Garcia-Montes JR; González-Granillo A; Xu M; Moratalla R
Cereb Cortex; 2017 Jan; 27(1):435-446. PubMed ID: 26483399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
